ABCL logo

AbCellera Biologics Inc. (ABCL) Free Cash Flow

Annual FCF:

-$186.95M-$65.57M(-54.02%)
December 31, 2024

Summary

  • As of today, ABCL annual free cash flow is -$186.95 million, with the most recent change of -$65.57 million (-54.02%) on December 31, 2024.
  • During the last 3 years, ABCL annual free cash flow has fallen by -$373.08 million (-200.44%).
  • ABCL annual free cash flow is now -191.33% below its all-time high of $204.70 million, reached on December 31, 2022.

Performance

ABCL Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLcash flow metrics

Quarterly FCF:

-$47.01M-$24.82M(-111.85%)
June 1, 2025

Summary

  • As of today, ABCL quarterly free cash flow is -$47.01 million, with the most recent change of -$24.82 million (-111.85%) on June 1, 2025.
  • Over the past year, ABCL quarterly free cash flow has increased by +$2.25 million (+4.56%).
  • ABCL quarterly free cash flow is now -119.56% below its all-time high of $240.37 million, reached on June 30, 2022.

Performance

ABCL Quarterly Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLcash flow metrics

TTM FCF:

-$137.24M+$2.25M(+1.61%)
June 1, 2025

Summary

  • As of today, ABCL TTM free cash flow is -$137.24 million, with the most recent change of +$2.25 million (+1.61%) on June 1, 2025.
  • Over the past year, ABCL TTM free cash flow has increased by +$31.57 million (+18.70%).
  • ABCL TTM free cash flow is now -148.86% below its all-time high of $280.91 million, reached on June 30, 2022.

Performance

ABCL TTM Free Cash Flow Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABCLcash flow metrics

Free Cash Flow Formula

FCF = Cash From Operations − CAPEX

ABCL Free Cash Flow Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1Y1 Year-54.0%+4.6%+18.7%
3Y3 Years-200.4%-119.6%-148.9%
5Y5 Years-10000.0%-311.1%-1698.3%

ABCL Free Cash Flow Highs & Lows

PeriodPeriodAnnual vs HighAnnual vs HighAnnual vs LowAnnual vs LowQuarter. vs HighQuarter. vs HighQuarter. vs LowQuarter. vs LowTTM vs HighTTM vs HighTTM vs LowTTM vs Low
3Y3-Year-191.3%at low-449.0%+67.2%-169.9%+30.1%
5Y5-Year-191.3%at low-119.6%+67.2%-148.9%+30.1%
All-TimeAll-Time-191.3%at low-119.6%+67.2%-148.9%+30.1%

ABCL Free Cash Flow History

DateAnnualQuarterlyTTM
Jun 2025
-
-$47.01M(-111.9%)
-$137.24M(+1.6%)
Mar 2025
-
-$22.19M(-8.5%)
-$139.49M(+23.8%)
Dec 2024
-$186.95M(-54.0%)
-$20.46M(+57.0%)
-$183.14M(+6.2%)
Sep 2024
-
-$47.58M(+3.4%)
-$195.26M(-15.7%)
Jun 2024
-
-$49.26M(+25.2%)
-$168.81M(-32.8%)
Mar 2024
-
-$65.85M(-102.1%)
-$127.09M(-5.7%)
Dec 2023
-$121.38M(-159.3%)
-$32.58M(-54.2%)
-$120.29M(-62.0%)
Sep 2023
-
-$21.13M(-180.5%)
-$74.24M(+62.2%)
Jun 2023
-
-$7.53M(+87.2%)
-$196.38M(-481.2%)
Mar 2023
-
-$59.05M(-538.3%)
$51.52M(-73.8%)
Dec 2022
$204.70M
$13.47M(+109.4%)
$196.29M(+25.3%)
Sep 2022
-
-$143.28M(-159.6%)
$156.61M(-44.2%)
DateAnnualQuarterlyTTM
Jun 2022
-
$240.37M(+180.4%)
$280.91M(+70.3%)
Mar 2022
-
$85.72M(+427.1%)
$164.94M(-10.9%)
Dec 2021
$186.13M(+2221.7%)
-$26.21M(-38.1%)
$185.12M(-12.4%)
Sep 2021
-
-$18.98M(-115.3%)
$211.23M(-5.2%)
Jun 2021
-
$124.40M(+17.5%)
$222.86M(+84.6%)
Mar 2021
-
$105.90M(>+9900.0%)
$120.73M(+1322.9%)
Dec 2020
$8.02M(+715.3%)
-$101.70K(+98.6%)
$8.48M(-1.2%)
Sep 2020
-
-$7.34M(-133.0%)
$8.59M(-46.1%)
Jun 2020
-
$22.27M(+450.9%)
$15.93M(+350.9%)
Mar 2020
-
-$6.35M
-$6.35M
Dec 2019
-$1.30M(+25.2%)
-
-
Dec 2018
-$1.74M
-
-

FAQ

  • What is AbCellera Biologics Inc. annual free cash flow?
  • What is the all-time high annual free cash flow for AbCellera Biologics Inc.?
  • What is AbCellera Biologics Inc. annual free cash flow year-on-year change?
  • What is AbCellera Biologics Inc. quarterly free cash flow?
  • What is the all-time high quarterly free cash flow for AbCellera Biologics Inc.?
  • What is AbCellera Biologics Inc. quarterly free cash flow year-on-year change?
  • What is AbCellera Biologics Inc. TTM free cash flow?
  • What is the all-time high TTM free cash flow for AbCellera Biologics Inc.?
  • What is AbCellera Biologics Inc. TTM free cash flow year-on-year change?

What is AbCellera Biologics Inc. annual free cash flow?

The current annual free cash flow of ABCL is -$186.95M

What is the all-time high annual free cash flow for AbCellera Biologics Inc.?

AbCellera Biologics Inc. all-time high annual free cash flow is $204.70M

What is AbCellera Biologics Inc. annual free cash flow year-on-year change?

Over the past year, ABCL annual free cash flow has changed by -$65.57M (-54.02%)

What is AbCellera Biologics Inc. quarterly free cash flow?

The current quarterly free cash flow of ABCL is -$47.01M

What is the all-time high quarterly free cash flow for AbCellera Biologics Inc.?

AbCellera Biologics Inc. all-time high quarterly free cash flow is $240.37M

What is AbCellera Biologics Inc. quarterly free cash flow year-on-year change?

Over the past year, ABCL quarterly free cash flow has changed by +$2.25M (+4.56%)

What is AbCellera Biologics Inc. TTM free cash flow?

The current TTM free cash flow of ABCL is -$137.24M

What is the all-time high TTM free cash flow for AbCellera Biologics Inc.?

AbCellera Biologics Inc. all-time high TTM free cash flow is $280.91M

What is AbCellera Biologics Inc. TTM free cash flow year-on-year change?

Over the past year, ABCL TTM free cash flow has changed by +$31.57M (+18.70%)
On this page